Therefore, inhibition of HIF-1 and improvement of MHC class I expression on cancer cells is important to induce effective responses of cell-mediated immunity against cancer such as lung cancer for immunotherapies, including PD-1/PD-L1 inhibitor. This evidence concerns the gene HIF1A and lung cancer.